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1. Complete List of Authors for Ref. 23 
(23) Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, 
N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; 
Jacobson, A.; Pappin, D. J. Mol. Cell. Proteomics 2004, 3, 1154. 
 
2. Materials 
Allyl bromide-d5 was purchased from C/D/N isotopes Inc. (Quebec, Canada). MagneHis Ni-Particles 
and sequencing grade trypsin was purchased from Promega (Madison, WI). The model peptide, VIP 
(residue 1-12), HSDAVFTDNYTR, was acquired from Anaspec (Fremont, CA). High Capacity 
Neutravidin Agarose Resin, n-dodecyl-β-D-maltoside, and SuperSignal West Dura Extended Duration 
chemiluminescent substrate were from Thermo Scientific (Rockford, IL). Lysyl endopeptidase (LysC) 
was from Wako Chemicals USA (Richmond, VA). Cell culture reagents, Flip-In T-REx 293 cells, 
plasmids, and monoclonal antibodies for Cul1 and Cand1 were from Invitrogen (Carlsbad, CA). Plasmid 
DNA containing the human Cul1 sequence was purchased from Open Biosystems (Huntsville, AL). 
MLN4924 was a generous gift from Millennium: The Takeda Oncology Company (Cambridge, MA). 
All other general chemicals were purchased from Fisher Scientific (Hampton, NH), VWR International 
(West Chester, PA), and Sigma-Aldrich (St. Louis, MO) and used as received without further 
purification. 
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3. Synthesis of Caltech Isobaric Tags 
Figure S1. Synthesis of CIT 
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Figure S1. Synthesis of CIT reagents. a) THF, K2CO3, TEAI, reflux 18 h, 56%. b) THF, K2CO3, TEABr, reflux 18 h, R1 = 
Allyl-d0-bromide, 56% (4a), R1 = Ally-d5-bromide, 67% (4b). c) 0.4 eq Na ascorbate, 0.1 eq CuSO4, 0.01 eq TBTA, 
DMSO/H2O, RT 4 h, R2 = Allyl-d5-azide, 72% (heavy tag, 5a), R2 = Allyl-d0-azide, 69% (light tag, 5b). d) 2M KOH, THF, 
RT overnight, quantitative (heavy tag, 6a), 97% (light tag, 6b). e) TFA-NHS, DMF, RT overnight, 24% (heavy tag, 7a), 23% 
(light tag, 7b). THF = tetrahydrofuran, TEAI = tetraethylammonium iodide, TEABr = tetraethylammonium bromide, TBTA 
= tris[(1-t-butyl-1H-1,2,3-triazol-4-yl)methyl]amine, DMSO = dimethyl sulfoxide, TFA-NHS = trifluoroacetic N-
hydroxysuccinimide ester, DMF = N,N'-dimethyl formamide. 
6-Iodo-hex-1-yne (1) 
In a flame-baked, one neck 250 mL round bottom flask, 40 mmol of 6-chloro-1-hexyne (~5 mL) was 
dissolved in 25 mL of acetone with 80 mmol of sodium iodide (~12 g) and refluxed for 2 days with thin 
layer chromatography (TLC) check. After filtration, the mixture was diluted by diethylether. The 
organic layer was washed with water, Na2S2O4 and brine and dried over MgSO4. The resulting solution 
was concentrated in vacuo with caution (the product is slightly volatile). The desired product, 6-iodo-1-
hexyne (5.58 g, 26.4 mmol, 1) was acquired as a brownish oil. Yield: 66% 
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N-(5-hexynyl) L-alanine methyl ester (3) 
In a flame-baked, two neck 100 mL round bottom flask, 20 mmol of L-alanine methyl ester 
hydrochloride, 2 (2.8 g), 40 mmol of K2CO3 (5.53 g), and 20 mmol of tetrabutylammonium iodide 
(TBAI, 7.39 g) were charged under a stream of dry N2 gas. 35 mL of tetrahydrofuran (THF) was slowly 
added and stirred for 15 min at RT. Then 2.6 mL of 6-iodo-hex-1-yne was added dropwise while the 
mixture was stirred. The reaction mixture was refluxed at ~70°C for 15-18 h with TLC check. After 
consumption of the starting material, the mixture was cooled to RT, diluted with diethylether, and 
filtered. The filtrate was further diluted with diethylether and filtered again. The solvent was removed in 
vacuo and the crude product was purified by flash chromatography on silica gel (1:2 = Hexane/EtOAc, 
1% triethylamine) to give N-(5-hexynyl) L-alanine methyl ester (2.044 g, 11.2 mmol, 3) as a yellow oil. 
Yield: 56%. Rf  = 0.27 (1:1 = Hexane/EtOAc); ESI-MS [M+H]+ = m/z 184.1; 1H NMR (300 MHz, 
CDCl3): δ 3.70 (s, 3H), 3.32 (q, J = 7.0 Hz, 1H), 2.53 (m, 2H), 2.18 (m, 2H), 1.92 (t, J = 2.6 Hz, 1H), 
1.56 (m, 5H), 1.27 (d, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 176.29, 84.21, 68.41, 56.61, 
51.74, 47.41, 29.20, 26.01, 19.11, 18.23. 
N,N-(5-hexynyl)(allyl-d0) L-alanine methyl ester (4a) and N,N-(5-hexynyl)(allyl-d5) L-alanine methyl 
ester (4b) 
In a flame-baked, two neck 50 mL round bottom flask, 10 mL THF was charged under a stream of dry 
N2 gas. 6 mmol of K2CO3 (0.83 g), and 6 mmol of tetrabutylammonium bromide (TBAB, 1.93 g) were 
slowly added and stirred for 15 min at RT. 3 mmol (0.55 g) of 3 , and 4.5 mmol of allyl bromide-d0 
(0.544g, 0.38 mL) were slowly added dropwise using a syringe while the mixture was stirred. The 
reaction mixture was heated at ~55°C and reacted for 8 h with TLC check. After consumption of the 
starting material, the mixture was cooled to RT, diluted with diethylether and filtered. Filtration was 
repeated twice to remove the remaining TBAB completely. The solvent was removed in vacuo and the 
crude product was purified by flash chromatography on silica gel (20:1 = Hexane/EtOAc) to give 4a 
(0.378 g, 1.69 mmol) as a transparent oil. Yield: 56%. Rf  = 0.4 (5:1 = Hexane/EtOAc); ESI-MS 
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[M+H]+ = m/z 224.2; 1H NMR (300 MHz, CDCl3): δ 5.79 (m, 1H), 5.12 (m, 2H), 3.67 (s, 3H), 3.54 (q, J 
= 7.3 Hz, 1H), 3.18 (m, 2H), 2.53 (m, 2H), 2.18 (m, 2H), 1.93 (t, J = 2.7 Hz, 1H), 1.52 (m, 4H), 1.24 (d, 
J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 174.45, 136.86, 116.78, 84.47, 68.24, 57.79, 54.20, 
51.21, 49.85, 27.40, 26.07, 18.26, 14.88. 
0.457g of N,N-(5-hexynyl)(allyl-d5) L-alanine methyl ester (4b) (2.0 mmol) was obtained by the same 
procedure described above using 3.55 mmol of allyl bromide-d5 (0.448 g). Yield: 67%. Rf  = 0.4 (5:1 = 
Hexane/EtOAc); ESI-MS [M+H]+ = m/z 229.3; 1H NMR (500 MHz, CDCl3): δ 3.68 (s, 3H), 3.54 (q, J = 
7.08 Hz, 1H), 2.53 (m, 2H), 2.18 (m, 2H), 1.93 (t, J = 2.68 Hz, 1H), 1.52 (m, 4H), 1.25 (d, J = 7.08 Hz, 
3H); 13C NMR (125 MHz, CDCl3): δ 174.47, 136.16 (t, J = 23.48 Hz), 116.25 (quintet, J = 23.47 Hz), 
84.47, 68.27, 57.76, 53.28 (quintet, J = 18.41 Hz), 51.22, 49.79, 27.39, 26.07, 18.26, 14.90. 
Allyl-d0 azide and allyl-d5 azide 
0.5 M NaN3 in DMSO was prepared as described in the literature by stirring the mixture at room 
temperature overnight.1 1.1 eq of 0.5 M NaN3 solution was mixed with the appropriate amount of allyl 
bromide (d0/d5) and stirred overnight. TLC monitored for the complete consumption of the starting 
material; unwanted dimerization of allyl azides was not observed in this condition. The resulting 
mixtures were used for the next steps without further purification or analysis. 
N,N-(4-(1-allyl-d5-1H-1,2,3-triazol-4-yl)butyl)(allyl-d0) L-alanine methyl ester (5a) and N,N-(4-(1-
allyl-d0-1H-1,2,3-triazol-4-yl)butyl)(allyl-d5) L-alanine methyl ester (5b) 
The literature procedure was followed with some modifications.2 To in situ prepared allyl-d5 azide 
solution (~1.2 eq), 1.7 mmol (0.378 g) of 4a, 0.17 mmol of CuSO4·5H2O (42.5 mg, 0.1 eq), 0.68 mmol 
of sodium ascorbate (134.7 mg, 0.4 eq), 0.017 mmol of tris[(1-t-butyl-1H-1,2,3-triazol-4-
yl)methyl]amine (TBTA) (7.3 mg, 0.01 eq), and an additional 2 mL of DMSO were added and stirred 
for 2 h at RT. Then, 2.4 mL of water was added and stirred for additional 2 h with TLC monitoring. 
After the complete consumption of the starting material, 4 mL of 1M NH4OH was added to remove 
residual CuN3 and (Cu)2N3. The mixture was diluted using additional water and ethyl acetate. The 
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aqueous layer turned blue due to the coordination of ammonia to copper ions. The organic layer was 
separated, and further extracted by ethyl acetate three times. The combined organic layer was then 
washed with brine, dried over MgSO4 and concentrated in vacuo. The crude product was purified by 
flash chromatography on silica gel (1:1 = Hexane/EtOAc, 1% triethylamine) to give 5a (0.379 g, 1.22 
mmol) as a transparent oil. Yield: 72%. Rf  = 0.3 (1:1 = Hexane/EtOAc); ESI-MS [M+H]+ = m/z 312.3, 
CID of [M+H]+ produced m/z 169.1 fragment; 1H NMR (500 MHz, CDCl3): δ 7.25 (s, 1H), 5.76 (m, 
1H), 5.14 (dd, J = 17.1, 1.22 Hz, 1H), 5.04 (d, J = 10 Hz, 1H), 3.64 (s, 3H), 3.51 (q, J = 7.08 Hz, 1H), 
3.21 (dd, J = 14.6, 5.6 Hz, 1H), 3.09 (dd, J = 14.4, 6.9 Hz, 1H), 2.68 (t, J = 7.6 Hz, 2H), 2.52 (m, 2H), 
1.54 (m, 4H), 1.21 (d, J = 7.08 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 174.46, 148.43, 136.81, 130.94 
(t, J = 24.9 Hz), 120.40, 119.21 (quintet, J = 24.9 Hz), 116.82, 57.85, 54.25, 51.85 (quintet, J = 23.9 Hz), 
51.24, 50.20, 27.97, 27.06, 25.54, 14.83. 
1.59 mmol of 4b (0.363 g) was used for the same reaction described above to give 5b (0.341 g, 1.10 
mmol) as a transparent oil. Yield: 69%. Rf  = 0.3 (1:1 = Hexane/EtOAc); ESI-MS [M+H]+ = m/z 312.3, 
CID of [M+H]+ produced m/z 164.1 fragment; 1H NMR (500 MHz, CDCl3): δ 7.25 (s, 1H), 5.98 (m, 
1H), 5.30 (dd, J = 10, 0.9 Hz, 1H), 5.25 (d, J = 17.1 Hz, 1H), 4.91 (d, J = 6.1 Hz, 2H), 3.65 (s, 3H), 3.51 
(q, J = 7.1 Hz, 1H), 2.69 (t, J = 7.6 Hz, 2H), 2.52 (m, 2H), 1.55 (m, 4H), 1.22 (d, J = 7.1 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ 174.49, 148.45, 136.12 (t, J = 23 Hz), 116.29 (quintet, J = 22.6 Hz), 120.43, 
119.78, 57.84, 53.33 (quintet, J = 19.3 Hz), 52.55, 51.24, 50.15, 27.98, 27.07, 25.55, 14.85. 
N,N-(4-(1-allyl-d5-1H-1,2,3-triazol-4-yl)butyl)(allyl-d0) L-alanine (6a) and N,N-(4-(1-allyl-d0-1H-
1,2,3-triazol-4-yl)butyl)(allyl-d5) L-alanine (6b) 
1.22 mmol of 5b (0.375 g) was charged to a 10mL one neck flask with 2 mL of THF and 2 mL of 2M 
KOH and stirred at RT for 10 h. The reaction was monitored by TLC and ESI-MS until the starting 
material was completely consumed. Upon completion of the reaction, THF was removed in vacuo and 
the aqueous layer was neutralized by ~2 mL of 2M HCl. Water was then completely removed in vacuo 
and the residue was reconstituted in acetonitrile (ACN). Insoluble KCl salt was filtered and ACN was 
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removed in vacuo. The free acid of the alanine derivative, N,N-(4-(1-allyl-d5-1H-1,2,3-triazol-4-
yl)butyl)(allyl-d0) L-alanine (6a) was recovered as a pale yellow oil. Yield: quantitative. ESI-MS 
[M+H]+ = m/z 298.1; 1H NMR (500 MHz, DMSO-d6): δ 10.62 (br, 1H), 7.90 (d, J = 2.2 Hz, 1H), 6.05 
(m, 1H), 5.53 (d, J = 17.1 Hz, 1H), 5.45 (d, J = 10.5 Hz, 1H), 4.18 (q, J = 7.1 Hz, 1H), 3.83 (m, 2H), 
3.15 (br, 2H), 2.64 (t, J = 7.6 Hz, 2H), 1.69 (m, 4H), 1.52 (d, J = 6.9 Hz, 3H). 
Hydrolysis of 5b (0.247 g, 0.79 mmol) using above-described procedure gave 0.230 g of 6b (0.773 
mmol) as a pale yellow oil. Yield: 97%. ESI-MS [M+H]+ = m/z 298.1; 1H NMR (500 MHz, DMSO-d6): 
δ 10.54 (br, 1H), 7.89 (d, J = 4.2 Hz, 1H), 6.03 (m, 1H), 5.25 (m, 1H), 5.16 (m, 1H), 4.98 (m, 2H), 4.18 
(q, J = 7.1 Hz, 1H), 3.15 (br, 2H), 2.64 (t, J = 7.3 Hz, 2H), 1.69 (m, 4H), 1.52 (d, J = 7.1 Hz, 3H).  
N,N-(4-(1-allyl-d5-1H-1,2,3-triazol-4-yl)butyl)(allyl-d0) L-alanine N-hydroxylsuccinimide ester (7a) 
and N,N-(4-(1-allyl-d0-1H-1,2,3-triazol-4-yl)butyl)(allyl-d5) L-alanine N-hydroxylsuccinimide ester (7b) 
In a flame-baked 50 mL one neck flask, 2.75g of N-hydroxysuccinimide was added to 14 mL of 
trifluoroacetic anhydride at RT under a stream of dry N2 gas and stirred for 4 h. The solvent was 
removed in vacuo overnight. A white crystalline product, trifluoroacetic N-hydroxysuccinimide ester 
(TFA-NHS) was obtained, stored in a dry desiccator, and used just before activation of free acids. 
In a flame-baked 50 mL one neck flask, 87 mg of 6a (0.29 mmol) and 75 mg of TFA-NHS were 
added to 1 mL of dry DMF, and stirred overnight at RT. After the complete consumption of the starting 
material (monitored by TLC), the reaction mixture was separated by flash chromatography on silica gel 
(1:1 = Hexane/EtOAc) and yielded 28 mg of 7a (~0.7 mmol) as a yellow oil. (Note: the poor recovery 
yields for the final products are observed due to the retained products on silica gel through the 
coordination of the highly N-substituted residues such as the 1,2,3-triazole and the tertiary amine. Other 
purification methods such as crystallization would improve the overall yield.) Yield: 24%. ESI-MS 
(100% ACN) [M+H]+ = m/z 395.1. The stock solution of the heavy tag (m/z 169 reporter ion) was 
prepared without further analysis by adding 20 µL dry DMSO to 1 mg of the NHS-ester product into 
each vial. Stock solutions were stored at −80°C. Each vial contained 1 mg of the reagent and was used 
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for each labeling experiment. 
The same procedure was used for NHS ester activation of 52 mg of 6b (0.175 mmol) and yielded 16 
mg of the NHS-ester product 7b. Yield: 23%. ESI-MS (100% ACN) [M+H]+ = m/z 395.1. The stock 
solution vials of the light tag (m/z 164 reporter ion) were prepared as described above and stored at 
−80 °C. 
 
4. Synthesis of iTRAQ-113 Reagent 
Methyl 2-(4-methylpiperazin-1-yl)acetate (8) 
To a mixture of 5 mmol of 1-methyl piperazine (0.5 g) and 6 mmol of K2CO3 (0.83 g) in a flame-
baked, two neck 100 mL round bottom flask under a stream of dry N2 gas was slowly added 15mL of 
tetrahydrofuran (THF) and stirred for 15 min at RT. While the mixture was stirred, 0.56 mL of methyl 
boromoacetate was added dropwise. The mixture was reacted at RT for 15-18 h with TLC check. After 
consumption of the starting material, the mixture was diluted with diethylether, and filtered. The solvent 
was removed in vacuo and the crude product was purified by flash chromatography on silica gel (5:1 = 
CHCl3/MeOH) to methyl 2-(4-methylpiperazin-1-yl)aceate (0.111 g, 0.65 mmol) as a pale yellow oil. 
Yield: 13%. Rf  = 0.36 (5:1 = CHCl3/MeOH); ESI-MS [M+H]+ = m/z 173.1, CID of [M+H]+ produced 
m/z 113.0 fragment; 1H NMR (300 MHz, CDCl3): δ 3.68 (s, 3H), 3.18 (s, 2H), 2.52 (m, broad, 8H), 2.26 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ 170.70, 59.36, 54.71, 52.94, 51.70, 45.91. 
2-(4-methylpiperazin-1-yl)acetic acid (9) 
To a 10mL one neck flask with 2 mL of THF and 2 mL of 2M KOH, 51.3 mg of methyl 2-(4-
methylpiperazin-1-yl)acetate was added and stirred at RT for 10 h. The reaction was monitored by TLC 
and ESI-MS until the starting material was completely consumed. Upon completion of the reaction, 
THF was removed in vacuo and the aqueous layer was neutralized using ~2 mL of 2M HCl. Water was 
then completely removed in vacuo and the residue was reconstituted by acetonitrile (ACN). Insoluble 
KCl salt was filtered and ACN was removed in vacuo. The free acid of the product was recovered as a 
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transparent gleasy oil. Yield: quantitative. ESI-MS [M+H]+ = m/z 159.1. 
N-hydroxylsuccinimide 2-(4-methylpiperazin-1-yl)acetate ester (iTRAQ-113) (10) 
In a flame-baked 15 mL glass vial, ~0.65 mmol of 2-(4-methylpiperazin-1-yl)acetic acid and 33.0 mg 
of TFA-NHS were added to 0.5 mL of dry DMF and 101 mg of N,N-diisopropylethylamine, and stirred 
overnight at RT. After the complete consumption of the starting material (TLC monitoring), the reaction 
mixture was used for peptide labeling without further purification. ESI-MS (100% ACN) [M+H]+ = m/z 
256.1. The stock solution vials of the iTRAQ-113 reagent (m/z 113 reporter ion) were prepared as 
described above and stored at −80 °C. 
 
5. Protein Sample Preparation 
Protein mixture digestion 
Equal amounts (by weight) of protein mixtures, bovine serum albumin, ovalbumin, α- and β-caseins, 
lysozyme were dissolved in water, reduced by 10 mM dithiothreitol (DTT) for 30 min at room 
temperature, alkylated by 5 mM iodoacetamide for 1 h in the dark and digested by trypsin (50:1, w/w) in 
50 mM ammonium bicarbonate buffer for 15 h at 37 °C. The reaction was quenched by 5% formic acid, 
and the resulting peptide products were desalted with C18 spin columns (Satorious Stedim Biotech, 
Aubagne Cedex, France). 
Affinity purification and digestion of Cul1 and its associated proteins 
The applicability of CIT to the quantification of protein complexes in the cell was evaluated with 
Cul1. Cul1 is a ubiquitin ligase that attaches a ubiquitin chain on target substrates for proteasome-
catalyzed degradation.3 Cul1 is a prototype of the cullin ligase family, and constitutes modular ligase 
complexes with many confirmed binding partners. The purification of Cul1 and its binding partners 
from the cells was carried out as described previously with minor modifications.4 Briefly, to facilitate 
the purification of Cul1, a HEK 293-derived stable cell line capable of expressing tagged Cul1 upon 
tetracycline treatment was constructed using the T-RExTM (Tetracycline-regulated Expression) system 
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(Invitrogen, Carlsbad, CA). The tandem tag we adopted consists of a hexa-histidine sequence and a 
biotinylation signal sequence.5 Biotinylation is catalyzed by endogenous biotin ligases, which are 
present in all eukaryotic cells.6 A specific lysine residue in the biotinylation signal sequence functions as 
an acceptor site for biotin in vivo.7 
Tagged Cul1 was induced with 1.0 µg/mL tetracycline for 4 h in the experiments aimed to quantify 
purified Cul1 complexes with an initial 1:2 mixing ratio for the light and heavy CIT labeling. For the 
quantification of differentially expressed Cul1 in the cell, 0.5 or 2.0 µg/mL tetracycline were added to 
the growth medium for 1 h or 4 h, respectively. Twenty-four hours after induction, cells were harvested 
and lysed for 30 min at 4 °C with the lysis buffer (0.050 M HEPES, pH 7.5, 0.0050 M Mg(OAc)2, 
0.070 M KOAc, 10% glycerol, and 0.4% IGEPAL CA630). The lysate was centrifuged at 16,600 g at 4 
°C for 20 min and the supernatant was used for purification. Tandem purification of tagged Cul1 and 
associated proteins was carried out using MagneHis Ni-particles from Promega and Streptavidin-
coupled Dynabeads from Invitrogen. Purified proteins were subjected to reduction by 10 mM DTT and 
alkylation by 5 mM chloroacetamide, sequential on-bead protease digestions, first with Lys-C (35 
ng/mg lysate) for 4 h at 37 °C in 8 M urea (freshly prepared), and then with trypsin (30 ng/mg lysate) 
for 12 h at 37 °C in 2 M urea (freshly prepared). The resulting tryptic peptides were desalted with C18 
spin columns. 
CIT Labeling 
The model peptide, VIP (residue 1-12, HSDAVFTDNYTR; 50 µg), was dissolved in 50 µL of 100 
mM tetraethylammonium bicarbonate (pH 8.5) and 100 µL of ACN (66.7% organic phase) and labeled 
with 5 µL of 5 µg/µL DMSO stock solution of either light or heavy tag, by incubating for 2 h at RT. The 
reaction was quenched by adding 50 µL of 100 mM hydroxylamine and incubated for 7 h at RT. The 
mixture was acidified by adding 4 µL of formic acid and completely dried in vacuo. The residue was 
reconstituted using 100 µL of 0.1% formic acid, desalted using the C18 desalting tip, and eluted to 100 
µL of 0.1% formic acid, 50% ACN and 50% water. The CIT labeled VIP peptide eluent was diluted 
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(~X20), and analyzed by various mass spectrometers. The iTRAQ-113 reagent labeling was performed 
using the same conditions for the CIT reagents. 
An aliquot of 1 µg of the protein digest was labeled using light or heavy CIT reagents under the same 
solvent system used for the model peptide, and mixed with a 1:1 ratio. The combined samples were 
desalted, and injected to a nanoLC-LTQ-Orbitrap mass spectrometer (Thermo Scientific, San Jose, CA) 
at Caltech. Approximately 3 µg of Cul1 digests were labeled by light or heavy CIT reagents with the 1:2 
ratio under the same solvent system used for the model peptide. After conjugation, light and heavy CIT-
labeled Cul1 digests were combined, desalted and injected to a nanoLC-LTQ-Orbitrap mass 
spectrometer at Caltech. For HCD/CID experiments, differentially expressed Cul1 digest samples were 
labeled by light or heavy CIT reagents. The resulting peptides were subject to a nanoLC-LTQ-Orbitrap 
XL mass spectrometer (Thermo Scientific, San Jose, CA) at UCLA for HCD/CID analyses. 
 
6. Instrumentation Setup 
Matrix-assisted laser desorption/ionization time-of-flight (MALDI TOF) spectra were acquired using 
Voyager DE-Pro mass spectrometer (Applied Biosystems, Foster City, CA) in the reflectron mode with 
a 20 kV acceleration voltage, a 150 ns delay extraction time and a 75% grid voltage. A 0.5 µL sample of 
the derivatized peptide solution was mixed with 0.5 µL of 10 mg/mL CHCA matrix solution in 0.1% 
TFA, 50% ACN, and 50% H2O and the mixed spots were dried and introduced to the mass spectrometer 
for analyses. For all spectra, 100 shots were averaged. 
PQD experiments via direct infusion for model peptide studies were performed by ion trap scans in an 
LTQ-FTICR mass spectrometer (Thermo, San Jose, CA) equipped with the Nanomate (Advion 
BioSciences Inc., Ithaca, NY) nanospray unit. The spraying voltage was 1.4 kV and the gas pressure 
was 0.3 psi. Critical parameters of the mass spectrometer include capillary voltage 49 V, capillary 
temperature 200 °C, and tube lens voltage 180 V. Other ion optic parameters were optimized by the 
auto-tune function in the LTQ tune program for maximizing the signal intensity. The parameters for 
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PQD experiments are the precursor isolation window 2.0 m/z, collision energy 29%, isolation Q 0.70, 
and activation time 0.1 ms. For PQD spectra, 100 scans were recorded. 
The samples were also analyzed by a nanoflow HPLC, Proxeon easy-nLC-System (Proxeon 
Biosystems) coupled on-line via a nanoelectrospray ion source (Proxeon Biosystems) to an LTQ-
Orbitrap mass spectrometer. Samples were loaded onto a C18-reversed phase column (15 cm long, 75 
µm inner diameter, packed in-house with ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch)) in buffer A 
(5% ACN, 0.2% formic acid) with a flow rate of 500 nl/min for 24 min and eluted with a linear gradient 
from 0% to 36% buffer B (80% ACN 0.2% formic acid) over 110 minutes, followed by 10 minutes at 
100% buffer B,  at a flow rate of 350 nl/min. The column was re-equilibrated with buffer A. Mass 
spectra were acquired in the positive ion mode applying data-dependent acquisition with automatic 
switching between survey scan and tandem mass spectrum acquisition. Samples were analyzed with a 
top 5 method; acquiring one Orbitrap survey scan in the mass range of m/z 400-1600 followed by 
MS/MS of the five most intense ions in the LTQ in the mass range of m/z 100-1600. The target value in 
the LTQ-Orbitrap was 500,000 for survey scan at a resolution of 60,000 at m/z 400. Fragmentation in the 
LTQ was performed by PQD with a target value of 5,000 ions. Selected sequenced ions were 
dynamically excluded for 30 s. General mass spectrometric conditions were: spray voltage, 2.4 kV; no 
sheath and auxiliary gas flow; ion transfer tube temperature, 200 °C; normalized collision energy (29%) 
using wide band activation mode for MS/MS. An activation of q = 0.55 and delay time of 0.4 ms were 
applied in MS/MS acquisitions.8 
For HCD/CID analyses, CIT-labeled peptides were loaded and washed on a 100 µm×35 mm CVC 
Microtech (Fontana, CA). Peptide trapping was performed using a New Objective Halo C18 75µm × 100 
mm, 90 Å, 2.7 µm (Woburn, MA) column by flushing a mobile phase of 0.1% formic acid in water (A). 
Peptides were subsequently eluted from the column at 300 nL/min using an Eksigent nanoLC 2D pump 
(Dublin, CA) with a 110 min gradient (0.1% formic acid in water (buffer A) and ACN containing 0.1% 
formic acid (buffer B); 0-30% phase B over 90min, 30-80% phase B over 20 min). The HPLC system 
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was coupled to an LTQ-Orbitrap XL mass spectrometer and the source conditions were as follows: 
capillary temperature, 180 °C; capillary voltage, 49 V; ESI spray voltage, 1.8 kV. The automatic gain 
control target was fixed at 500,000 ions for MS and 50,000 for MS/MS scans. The instrument was 
operated in data-dependent acquisition mode, with MS survey scan (m/z 400-1400) performed in the 
Orbitrap using a resolution set at 60,000. CID and HCD activations were performed on the 3 most 
abundant ions over 5,000 counts (charge state +1 rejected) using normalized collision energies of 30 and 
40, respectively, and detected using the linear ion trap. Ions with masses within 10 ppm of previously 
fragmented ions were excluded for 120s. 
For HCD analysis, a LTQ-Orbitrap Velos mass spectrometer (Thermo, San Jose, CA) was used with 
an Eksigent nanoLC 2D pump (Dublin, CA) as for HCD/CID analyses. Peptides were eluted from the 
column at 350 nL/min with a 80 min gradient (0.1% formic acid in water (buffer A) and ACN 
containing 0.1% formic acid (buffer B); 0-40% phase B over 70 min, 40-80% phase B over 10 min) and 
sprayed to the mass spectrometer. Samples were analyzed with a top 5 HCD method; acquiring one 
Orbitrap survey scan in the mass range of m/z 400-1800 followed by MS/MS of the five most intense 
ions in the HCD cell in the mass range of m/z 100-1600 at a resolution of 7,500. The target value in the 
LTQ-Orbitrap was 500,000 for survey scan at a resolution of 60,000 at m/z 400. Fragmentation in the 
HCD cell was performed with a target value of 50,000 ions, 40% normalized collision energy and 2.0 
m/z isolation window. Selected sequenced ions were dynamically excluded for 30 s. The critical 
parameters for the instruments were as follows: source voltage, 2.50 kV; capillary temperature, 180 °C; 
capillary voltage 49 V. 
7. Data Processing 
The raw files from LTQ-Orbitrap mass spectrometers were converted to Mascot generic format 
(MGF) files using ReAdW4Mascot (version 20090305a, available from the National Institute of 
Standards and Technology at http://peptide.nist.gov/software/ReAdW4Mascot2_20090305a.zip). PQD 
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of the CIT labeled model peptide acquired for testing of the linear dependency in reporter ion formation 
was then analyzed using in-house software and best-fit lines were calculated using linear regression. 
Error bars are displayed for the middle 95% reported ion ratios. For the five protein mixture, a database 
was constructed containing the five protein sequences as well as a small contaminant protein database. 
For the Cul1 pull-down search, a target sequence database was constructed from the human IPI database 
(version 3.54) and a small contaminant protein database. A decoy database was constructed from the 
target following the protocol as described elsewhere.9 The decoy database was then appended to the 
target and used to estimate the false discovery rate of the database search. The database search was 
performed using Mascot (version 2.2.06, Matrix Science, http://www.matrixscience.com). The database 
search parameters were as follows: 0.5 Da fragment ion mass tolerance, 10 ppm precursor ion mass 
tolerance, trypsin enzyme specificity, up to two missed cleavages, fixed carbamidomethyl (57.02146 
Da) modification of cysteine, variable modifications of oxidation (15.99491 Da) of methionine, 
carbamylation (43.005814 Da) of the N-terminal, and quantitation enabled. The Mascot quantitation 
parameters were as follows: fixed the N-terminal modification of 279.210745 Da with reporter ions at 
m/z 164.1188 and 169.1502, respectively. Reported proteins have at least one unique peptide sequence 
and two peptide ratios. Reported peptide ratios are included for those peptides whose score is above the 
homology level and outlier peptide ratios are discarded using the Mascot auto outlier detection. 
Reported Mascot protein quantitation ratios are the median of the top scoring peptide reporter ion ratios. 
The confidence intervals at 95% confidence level were determined by the home-built pearl script using 
the Bootstrap algorithm as implemented in pearl(x,y) 2.7.2.0.  
 
8. Density Functional Calculation 
The formation of the reporter ion is simulated by the N-protonated N,N-dimethyl-4-(1-methyl-1H-
1,2,3-triazol-4-yl)butan-1-amine. Initial coarse geometries were constructed by the MC/MM conformer 
search using Macromol 8.0 (Schrödinger Inc., Portland, OR, USA) as implemented in Maestro 8.0 
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(Schrödinger Inc., Portland, OR, USA). The OPLS 2005 was used for the force field model. Within 5 
kcal/mol energy, all low energy conformers were initially recorded. Low energy conformers were 
selected for further structure optimization by density functional theory (DFT). Each conformer was 
subject to a geometry optimization using Jaguar 7.5 (Schrödinger Inc., Portland, OR, USA) at the 
B3LYP/6-311++G(d,p) level. Thermochemical parameters of optimized conformers were estimated by 
vibrational frequency calculation at 1 atm and 298.15 K at the same level of theory. The transition state 
structures were searched using the QST method by interpolating initial guesses for reactants, products 
and transition states. All calculations were performed using computational resources kindly provided by 
the Material and Process simulation center at the Beckman Institute, Caltech. 
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9. Cartesian Coordinates of DFT Optimized Model Systems 
All structures were optimized by the B3LYP/6-311++G(d,p) level of theory. 
1) Reactant  
                                   angstroms 
  atom               x                 y                 z 
  N1            1.3378230058      1.1723051240     -1.8024698392 
  C2           -0.0629676997      1.5132733209     -2.1984521898 
  C3            1.4656684295     -0.2796917251     -1.4780601238 
  C4            1.8408983511      2.0507353878     -0.6744919783 
  C5            2.2377104457      3.4659278441     -1.1400895017 
  C6            3.7521721248      3.7368693445     -1.2316306171 
  C7            4.5909867621      2.7848483225     -2.1135964343 
  H8           -0.7388229186      1.2628353367     -1.3803908379 
  H9           -0.3257265354      0.9424578502     -3.0878938414 
  H10           5.6250327369      3.1363732819     -2.1051606316 
  H11           3.8818645436      4.7618501939     -1.5911611586 
  H12           4.6191390850      1.7854593289     -1.6645966977 
  C13           4.1323001212      2.6475962527     -3.5331461445 
  C14           4.6629211763      3.1084022064     -4.7187392055 
  N15           3.8202480429      2.6536925068     -5.6813765904 
  N16           2.8201422634      1.9526548570     -5.1525067194 
  N17           3.0085582355      1.9460337336     -3.8563937191 
  H18           5.5413189394      3.6896777795     -4.9424101893 
  C19           3.9059421071      2.8311772357     -7.1313110211 
  H20           3.9975408588      1.8578717122     -7.6116644340 
  H21           3.0097519476      3.3362482810     -7.4891386668 
  H22           4.7827886419      3.4353453166     -7.3542535708 
  H23          -0.1289385801      2.5760735228     -2.4211008542 
  H24           2.5153601615     -0.5156446294     -1.3096069123 
  H25           0.8861759251     -0.5058095374     -0.5826119503 
  H26           1.0923225524     -0.8651563082     -2.3170852985 
  H27           1.0463999570      2.0768828191      0.0732203034 
  H28           2.6905548437      1.5315446748     -0.2288663027 
  H29           1.7649350548      3.6867614214     -2.1008627154 
  H30           1.8158404483      4.1865797885     -0.4357196883 
  H31           4.1791760855      3.7121232108     -0.2236838232 
  H32           1.9570279710      1.3760677814     -2.6511743781 
 
  The zero point energy (ZPE):    181.178 kcal/mol 
  is not included in U, H, or G in the table below 
 
 
  T =   298.15 K 
 
              U         Cv          S          H          G        ln(Q) 
          ---------  ---------  ---------  ---------  ---------  --------- 
  trans.      0.889      2.981     41.522      1.481    -10.899   18.39467 
    rot.      0.889      2.981     31.563      0.889     -8.522   14.38288 
    vib.      6.568     44.348     40.636      6.568     -5.548    9.36330 
   elec.      0.000      0.000      0.000      0.000      0.000    0.00000 
   total      8.346     50.309    113.721      8.938    -24.968   42.14084 
 
  Total internal energy, Utot (SCFE + ZPE + U):    -573.022984 hartrees 
              Total enthalpy, Htot (Utot + pV):    -573.022040 hartrees 
    Total Gibbs free energy, Gtot (Htot - T*S):    -573.076073 hartrees 
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2) Transition state 
                                   angstroms 
  atom               x                 y                 z 
  C1           -2.6041842460      1.0544796483     -1.1194187389 
  N2           -1.5579899142      1.1108219162     -0.2595038202 
  N3           -1.1874925718     -0.0797439873      0.1274401846 
  N4           -2.0021185818     -0.9348210093     -0.4855180876 
  C5           -2.9006267189     -0.2845250729     -1.2696915238 
  C6           -1.8602118951     -2.3744454219     -0.2631524588 
  H7           -3.6482458388     -0.8016398124     -1.8474004714 
  H8           -1.6416106769     -2.8732714384     -1.2072862316 
  H9           -2.7790153610     -2.7730587377      0.1668462654 
  H10          -1.0352481236     -2.5176992799      0.4302920384 
  C11          -0.6308338039      2.8133139270      0.4072010224 
  C12          -3.1669175845      2.3160926647     -1.6932156524 
  C13          -2.7593690749      3.5439864973     -0.8631877832 
  C14          -1.2365024023      3.7083118676     -0.6581010269 
  H15           0.2892146950      2.2786355962      0.2471789613 
  H16          -1.1402488051      2.6667342068      1.3455253218 
  H17          -4.2563193161      2.2497315384     -1.7472710539 
  H18          -2.8133754008      2.4356246984     -2.7239595237 
  H19          -3.1301205978      4.4354356608     -1.3735370266 
  H20          -3.2582460283      3.5143892722      0.1115370915 
  H21          -1.0565026365      4.7480373111     -0.3778430109 
  H22          -0.7106663248      3.5515574565     -1.6042725096 
  N23           0.5922876320      4.2049968666      1.4269163409 
  C24           1.0286171012      3.5706943350      2.6834534042 
  C25           1.7189277228      4.6446919132      0.5848468104 
  H26           0.1594706697      3.3314362111      3.2979028429 
  H27           1.6974768779      4.2206227658      3.2562720187 
  H28           1.5601863403      2.6446606922      2.4536317916 
  H29           2.3023665369      3.7719250716      0.2833477133 
  H30           2.3806880243      5.3336363262      1.1193368335 
  H31           1.3436861936      5.1420963168     -0.3101004968 
  H32           0.0020818173      5.0044351458      1.6451627981 
 
  Imaginary vibrational frequency: -451.28 cm**-1 
 
  The zero point energy (ZPE):    179.336 kcal/mol 
  is not included in U, H, or G in the table below 
 
 
  T =   298.15 K 
    
              U         Cv          S          H          G        ln(Q) 
          ---------  ---------  ---------  ---------  ---------  --------- 
  trans.      0.889      2.981     41.522      1.481    -10.899   18.39467 
    rot.      0.889      2.981     31.944      0.889     -8.635   14.57465 
    vib.      7.296     46.706     48.442      7.296     -7.147   12.06272 
   elec.      0.000      0.000      0.000      0.000      0.000    0.00000 
   total      9.073     52.668    121.908      9.666    -26.681   45.03204 
     
  Total internal energy, Utot (SCFE + ZPE + U):    -572.969213 hartrees 
              Total enthalpy, Htot (Utot + pV):    -572.968269 hartrees 
    Total Gibbs free energy, Gtot (Htot - T*S):    -573.026191 hartrees 
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3) Product I: 2-methyl-4,5,6,7-tetrahydro-2H-[1,2,3]triazolo[1,5-a]pyridin-8-ium (reporter ion) 
                                   angstroms 
  atom               x                 y                 z 
  C1           -2.5004769446      1.2031337574     -1.2609782572 
  N2           -1.8896131518      1.6261477460     -0.1158108415 
  N3           -1.2521044682      0.6623024704      0.5146893836 
  N4           -1.4441149367     -0.4048904562     -0.2267839541 
  C5           -2.1991135267     -0.1403216784     -1.3256155941 
  C6           -0.8497742704     -1.6873934675      0.1781659719 
  H7           -2.4590602782     -0.8940797615     -2.0498189669 
  H8           -0.1189425949     -1.9959482718     -0.5685929154 
  H9           -1.6390201794     -2.4325398530      0.2687750186 
  H10          -0.3643878976     -1.5349802048      1.1384700574 
  C11          -1.9450974004      2.9956376917      0.4512238036 
  C12          -3.2649716362      2.1392095081     -2.1447990530 
  C13          -3.6038139186      3.4459709350     -1.4050222894 
  C14          -2.3850020916      3.9750457339     -0.6367233053 
  H15          -0.9553380281      3.2182941144      0.8480096489 
  H16          -2.6568954783      2.9668235114      1.2791620408 
  H17          -4.1670305321      1.6409720658     -2.5067027692 
  H18          -2.6509531315      2.3546502561     -3.0264957638 
  H19          -3.9433108849      4.1873575553     -2.1293458509 
  H20          -4.4350134593      3.2761145219     -0.7127186426 
  H21          -2.6161431288      4.9266561247     -0.1546590078 
  H22          -1.5550486853      4.1611591605     -1.3260235595 
   
The zero point energy (ZPE):    121.442 kcal/mol 
  is not included in U, H, or G in the table below 
 
 
  T =   298.15 K 
 
              U         Cv          S          H          G        ln(Q) 
          ---------  ---------  ---------  ---------  ---------  --------- 
  trans.      0.889      2.981     40.680      1.481    -10.648   17.97112 
    rot.      0.889      2.981     29.241      0.889     -7.830   13.21471 
    vib.      3.780     28.001     23.261      3.780     -3.155    5.32508 
   elec.      0.000      0.000      0.000      0.000      0.000    0.00000 
   total      5.558     33.962     93.182      6.150    -21.632   36.51092 
    
  Total internal energy, Utot (SCFE + ZPE + U):    -437.889571 hartrees 
              Total enthalpy, Htot (Utot + pV):    -437.888627 hartrees 
    Total Gibbs free energy, Gtot (Htot - T*S):    -437.932901 hartrees 
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4) Product II: dimethylamine 
                                   angstroms 
  atom               x                 y                 z 
  N23           1.1266745940      3.6313289106      1.5354574288 
  C24           1.4245055540      2.7223683368      2.6354993163 
  C25           2.1306322775      3.6108186510      0.4787356059 
  H26           0.6622602060      2.8211127866      3.4117687676 
  H27           2.4147072872      2.8854224495      3.0967179610 
  H28           1.3950939160      1.6907830016      2.2715297716 
  H29           2.1375066420      2.6247497587      0.0042594286 
  H30           3.1566440547      3.8190464459      0.8305161802 
  H31           1.8735199140      4.3451286367     -0.2881029631 
  H32           1.0138958118      4.5752239952      1.8873702930 
 
  The zero point energy (ZPE):     57.706 kcal/mol 
  is not included in U, H, or G in the table below 
 
 
  T =   298.15 K 
 
              U         Cv          S          H          G        ln(Q) 
          ---------  ---------  ---------  ---------  ---------  --------- 
  trans.      0.889      2.981     37.342      1.481     -9.652   16.29104 
    rot.      0.889      2.981     22.331      0.889     -5.769    9.73727 
    vib.      1.000      8.005      5.277      1.000     -0.573    0.96699 
   elec.      0.000      0.000      0.000      0.000      0.000    0.00000 
   total      2.778     13.966     64.949      3.370    -15.994   26.99530 
 
  Total internal energy, Utot (SCFE + ZPE + U):    -135.113157 hartrees 
              Total enthalpy, Htot (Utot + pV):    -135.112213 hartrees 
    Total Gibbs free energy, Gtot (Htot - T*S):    -135.143072 hartrees 
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